Results 11 to 20 of about 71,435 (301)

A Stepwise Framework for the Systematic Development of Lipid Nanoparticles

open access: yesBiomolecules, 2022
A properly designed nanosystem aims to deliver an optimized concentration of the active pharmaceutical ingredient (API) at the site of action, resulting in a therapeutic response with reduced adverse effects.
João Basso   +7 more
doaj   +1 more source

Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles

open access: yesPharmaceutics, 2021
Gastrointestinal absorption remains indispensable in the systemic delivery of most drugs, even though it presents several challenges that, paradoxically, may also provide opportunities that can be exploited to achieve maximal bioavailability.
Sui Ling Janet Tan, Nashiru Billa
doaj   +1 more source

Multifunctional nanocarriers for lung drug delivery [PDF]

open access: yes, 2020
Nanocarriers have been increasingly proposed for lung drug delivery applications. The strategy of combining the intrinsic and more general advantages of the nanostructures with specificities that improve the therapeutic outcomes of particular clinical ...
Grenha, Ana, Pontes, Jorge Filipe
core   +2 more sources

Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation

open access: yesPharmaceutics, 2021
Nanotherapeutics based on biocompatible lipid matrices allow for enhanced solubility of poorly soluble compounds in the treatment of ophthalmic diseases, overcoming the anatomical and physiological barriers present in the eye, which, despite the ease of ...
Felipe M. González-Fernández   +4 more
doaj   +1 more source

Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis

open access: yesMolecules, 2022
Solid lipid nanoparticles (SLNs) have been synthesized as potential drug delivery systems. They are classified as solid lipid nanocarriers that can successfully carry both hydrophilic and hydrophobic drugs.
Ewelina Musielak   +2 more
doaj   +1 more source

Development of Solid Lipid Nanoparticles for Controlled Amiodarone Delivery

open access: yesMethods and Protocols, 2023
In various drug delivery systems, solid lipid nanoparticles are dominantly lipid-based nanocarriers. Amiodarone hydrochloride is an antiarrhythmic agent used to treat severe rhythm disturbances.
Andreea Creteanu   +5 more
doaj   +1 more source

Nanoparticles in the treatment of chronic lung diseases [PDF]

open access: yes, 2019
Nanoparticles, although considered a topic of modern medicine, actually have an interesting history. Currently, advances in nanomedicine hold great promise as drug carrier systems for sustained release and targeted delivery of diverse therapeutic agents.
Alexescu, Teodora G   +9 more
core   +2 more sources

Native silica nanoparticles are powerful membrane disruptors [PDF]

open access: yes, 2015
Silica nanoparticles are under development for intracellular drug delivery applications but can also have cytotoxic effects including cell membrane damage.
Alkhammash, Hend I.   +3 more
core   +1 more source

Lipid Nanoparticles for Ocular Gene Delivery

open access: yesJournal of Functional Biomaterials, 2015
Lipids contain hydrocarbons and are the building blocks of cells. Lipids can naturally form themselves into nano-films and nano-structures, micelles, reverse micelles, and liposomes.
Yuhong Wang   +2 more
doaj   +1 more source

Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor models

open access: yesCancer Nanotechnology, 2023
Myricetin is a flavonoid with anticancer properties. This study aimed to formulate myricetin in the form of solid lipid nanoparticles (SLN), decorated with chitosan (CS) and active-targeted with folic acid (FA).
Niloufar Khatamian   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy